FDA approves first quadrivalent vaccine to prevent seasonal influenza

FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration. FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.

FDA announces safety changes in labeling for some cholesterol-lowering drugs

Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today by the U.S. Food and Drug Administration (FDA).

These products, when used with diet and exercise, help to lower a person’s “bad” cholesterol (low-density lipoprotein cholesterol). The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin), Pravachol (pravastatin), Crestor (rosuvastatin), and Zocor (simvastatin). Combination products include: Advicor (lovastatin/niacin extended-release), Simcor (simvastatin/niacin extended-release), and Vytorin (simvastatin/ezetimibe).

Voluntary Recall Of Goya, Great Value, Hatuey, Mr. Special, Polar, Publix, Regal, And SuperMax Brand Malta Beverages In 7-oz Bottles Due To Possible Health Risk

The Florida Brewery, Inc. is recalling certain lots of Goya, Great Value, Hatuey, Mr. Special, Polar, Publix, Regal, and SuperMax brand non-alcoholic malta beverages packaged in 7-oz bottles because glass on the exterior of the bottles may break when the twist-off cap is removed from the bottle and can result in cuts to the mouth. To date, the Company has received two reports of consumers experiencing cuts to the mouth.